Clinical Trial Update: FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating romidepsin (FR901228) in patients with myelodysplastic syndromes, acute myeloid leukemia, or non-Hodgkin lymphoma has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED